Definition, treatment and outcome of residual fragments in staghorn stones.
Percutaneous nephrolithotomy
Residual fragments
Staghorn
Staghorn stones
Stone management
Urolithiasis
Journal
Asian journal of urology
ISSN: 2214-3882
Titre abrégé: Asian J Urol
Pays: Singapore
ID NLM: 101699720
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
30
01
2019
revised:
28
05
2019
accepted:
29
11
2019
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
ppublish
Résumé
Technological advances in minimally invasive treatment of stone disease and its integration with concomitant clinical practice are amongst the most important achievements in urology. Despite the wealth of information accumulated over the years and the richness of existing literature, the knowledge about the definition, treatment and outcomes of residual stone fragments after percutaneous nephrolithotomy (PNL) is still insufficient. Due to the high stone load a lot of patients with staghorn stones have residual fragments (RFs) after treatment with PNL, which depends on the size of tract, definition of stone free rate (SFR), timing of evaluation and the imaging used. No consensus exists on the imaging modality or their timing in the evaluation of possible RFs. The treatment of residual stones is apparently different depending on the facilities of the department and the preference of the surgeon, which includes active surveillance, shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS) or a second look PNL.
Identifiants
pubmed: 32257804
doi: 10.1016/j.ajur.2019.12.013
pii: S2214-3882(19)30142-0
pmc: PMC7096689
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
116-121Informations de copyright
© 2020 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Eur Urol. 2005 Nov;48(5):832-7
pubmed: 16203078
J Endourol. 2014 Jul;28(7):767-74
pubmed: 24571713
Eur Urol. 2008 Dec;54(6):1393-403
pubmed: 18715696
Eur Urol. 2012 Jun;61(6):1188-93
pubmed: 22244778
J Endourol. 2013 Oct;27(10):1203-8
pubmed: 23924320
Urology. 2005 Apr;65(4):659-62; discussion 662-3
pubmed: 15833502
Curr Urol Rep. 2016 Dec;17(12):88
pubmed: 27771854
Urology. 2015 Sep;86(3):593-8
pubmed: 26126693
World J Urol. 2017 Nov;35(11):1651-1658
pubmed: 28593477
J Endourol. 2009 Oct;23(10):1669-73
pubmed: 19715482
World J Urol. 2017 Sep;35(9):1395-1399
pubmed: 28303335
Br J Urol. 1991 Aug;68(2):122-4
pubmed: 1884136
J Urol. 2005 Feb;173(2):469-73
pubmed: 15643212
Lasers Med Sci. 2017 Apr;32(3):649-654
pubmed: 28161725
J Endourol. 2011 Jan;25(1):11-7
pubmed: 21247286
J Endourol. 2014 Feb;28(2):152-7
pubmed: 24083829
PLoS One. 2019 Jan 31;14(1):e0206810
pubmed: 30703102
J Endourol. 2009 Mar;23(3):399-403
pubmed: 19250022
Urology. 2013 Apr;81(4):723-6
pubmed: 23465152
J Urol. 2005 Jun;173(6):1991-2000
pubmed: 15879803
Eur Urol. 2005 Jun;47(6):860-4
pubmed: 15925084
Urology. 2016 Nov;97:46-50
pubmed: 27421779
Urology. 2002 Jan;59(1):20-4
pubmed: 11796273
J Endourol. 2011 Aug;25(8):1263-8
pubmed: 21774666
J Endourol. 2011 Jun;25(6):941-5
pubmed: 21599528
Clin Radiol. 2017 Jan;72(1):11-15
pubmed: 27810168
Urolithiasis. 2014 Apr;42(2):95
pubmed: 24317839
Ther Adv Urol. 2016 Apr;8(2):142-6
pubmed: 27034726
F1000Res. 2016 Aug 30;5:2106
pubmed: 27703669
J Endourol. 2014 Jan;28(1):28-33
pubmed: 23987470
Kidney Int. 1979 Nov;16(5):624-31
pubmed: 548606
World J Urol. 2016 Aug;34(8):1163-8
pubmed: 26659063